STARmed to Accelerate Global Market Entry of EUSRA and ELRA Products through Olympus

February 14, 2024 06:00 AM PST | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 STARmed to Accelerate Global Market Entry of EUSRA and ELRA Products through Olympus
Image source: Kalkine Media

SEOUL, South Korea, Feb. 14, 2024 /PRNewswire/ -- STARmed, a leading developer and manufacturer of medical devices for tumor ablation, today announced global market expansion of its EUSRA and ELRA products, through Olympus, a global MedTech company based in Japan.

STARmed to Accelerate Global Market Entry of EUSRA and ELRA Products through Olympus
STARmed to Accelerate Global Market Entry of EUSRA and ELRA Products through Olympus

EUSRA and ELRA products had been distributed by Taewoong Medical Co., Ltd., a Korean manufacturer of gastrointestinal medical devices. With the completion of Olympus' acquisition of Taewoong Medical, Olympus has become a global distribution partner of STARmed's EUSRA and ELSA products. This will enable STARmed to accelerate its global market expansion and provide better healthcare to patients around the world.

"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."

"We recognize STARmed's EUSRA and ELRA products as well-received and high-quality products," said Mike Callaghan, Vice President, General Manager of GI EndoTherapy at Olympus. "Moving forward, we will further strengthen our position in this market, strive to elevate the standard of care, and in turn, offer new hope to patients and healthcare providers around the world."  

About EUSRA and ELRA

EUSRA is an endoscopic ultrasound-guided radiofrequency ablation system that is used to ablate accessible lesions in the gastrointestinal tract. ELRA is an endoluminal radiofrequency ablation system that is used to improve the symptoms of patients with bile duct strictures.

About STARmed Co., Ltd.

STARmed Co., Ltd is a South Korean-based medical device manufacturer specializing in thermal ablation technology. With a focus on radiofrequency ablation generators and electrodes, the company has gained global recognition for its innovative solutions and commitment to improving patient outcomes. STARmed's mission is to maintain high levels of innovation, knowledge, and technical expertise to provide solutions for patients' comfort and improve the quality of their lives.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (Content) is a service of Kalkine Media LLC., having Delaware File No. 4697309 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Recent Articles

Investing Tips

Previous Next